Search - inc

 
 
Japan Times
JAPAN / Science & Health
Oct 8, 2021

Japanese scientists work up an appetite for lab-grown wagyu beef

Environmental and ethical concerns around the meat industry have driven interest in vegetable alternatives and the potential for lab-grown products.
Japan Times
WORLD
Oct 8, 2021

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
COMMENTARY / World
Oct 8, 2021

Supply chain trouble might be the Grinch that steals Christmas

Retailers find themselves in an unusual situation of having to struggle to keep up with demand as vaccinated people socialize more and begin to splash their cash.
Japan Times
BUSINESS
Oct 8, 2021

China's energy crisis is hitting everything from iPhones to milk

Several companies have already experienced downtime at their Chinese facilities to comply with local restrictions.
Japan Times
BUSINESS / Companies
Oct 8, 2021

COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says

Competition to snag a piece of the COVID pill market is fierce, as the world adjusts to the virus being endemic.
Japan Times
ASIA PACIFIC
Oct 6, 2021

Singapore passes contentious law to counter foreign interference

Singapore has passed legislation that gives officials the authority to order internet service providers to disclose 'harmful' information from foreign entities.
Japan Times
BUSINESS / Companies
Oct 6, 2021

NEC plans overseas acquisitions in drive for 70% profit growth

The focus of acquisitions will be the United States and Europe, while expansion in Asia can come from organic growth, Chief Executive Officer Takayuki Morita has said.
Japan Times
BUSINESS
Oct 6, 2021

Amazon CEO is confident in its gaming products after New World release

A week ago, Amazon released New World, an online computer game where archers and ax wielders colonize a mythical land.
Japan Times
BUSINESS / Tech
Oct 4, 2021

Made-from-CO2 concrete, sportswear and diamonds spark investor excitement

Companies turning carbon dioxide into products have raised over $800 million so far this year, more than triple the amount seen in 2020.
Japan Times
BUSINESS
Oct 4, 2021

Christmas at risk as supply chain ‘disaster’ only gets worse

This holiday season might see more frowns than smiles, as the global supply chain faces unprecedented shortages.
Japan Times
BUSINESS
Oct 4, 2021

Why Australia's gender equality problem is costing the country billions

Political and economic life here is dominated by men to an even greater degree than in the United States, the United Kingdom or Canada.
Japan Times
JAPAN / History / JAPAN TIMES GONE BY
Oct 3, 2021

Japan Times 1971: Five men storm the Diet and hurl fire bombs

October 1971 saw many busy news days as the Emperor and Empress returned from a historic trip and there was a massive train crash. Meanwhile, Marxists were involved in a dangerous campaign.
JAPAN
Oct 1, 2021

Japan's Takeda says 'human error' caused contamination of Moderna vaccines

Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.
Japan Times
BUSINESS / Economy
Sep 30, 2021

What Japan’s middle-of-the-road new leader means for investors

For good or ill, Kishida is seen by investors as a continuity choice — stable, but unlikely to energize markets much.
Japan Times
BUSINESS / Tech
Sep 30, 2021

Developers are making games for a Nintendo 4K console that doesn’t exist

The lack of a console with 4K technology risks alienating developers who have spent months tailoring their games to take advantage of upgraded hardware capabilities.
Japan Times
COMMENTARY / World
Sep 29, 2021

Even the People’s Bank of China can’t kill Bitcoin's appeal

The bulls reckon the latest attempt by Beijing to crack down on crypto — the seventh — will fail to throttle an asset that bypasses borders and banking systems.
Japan Times
WORLD
Sep 29, 2021

Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids

A Pfizer spokesperson said the company expects to start and complete its application very soon.
Japan Times
JAPAN / Science & Health
Sep 27, 2021

Japan approves second drug for mildly ill COVID-19 patients

Sotrovimab was given the green light three weeks after GlaxoSmithKline's Japan unit submitted its application for the antibody treatment to the health ministry.

Longform

Japan's growing ranks of centenarians are redefining what it means to live in a super-aging society.
What comes after 100?